Volcano Corp  

(Public, NASDAQ:VOLC)   Watch this stock  
Find more results for VOLC
- Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 928.46M
P/E     -
Div/yield     -
EPS -0.74
Shares 51.61M
Beta     -
Inst. own 94%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -8.21% -8.76%
Operating margin -5.04% -7.60%
EBITD margin - 5.28%
Return on average assets -3.68% -3.98%
Return on average equity -10.48% -9.74%
Employees 1,800 -
CDP Score - -


3721 Valley Centre Dr Ste 500
SAN DIEGO, CA 92130-3328
United States - Map
+1-800-2284728 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Volcano Corporation designs, develops, manufactures and commercializes a suite of precision guided therapy tools including intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products. The Company markets its products to physicians, nurses and technicians who perform endovascular based coronary and peripheral interventional procedures in hospitals and to other personnel who make purchasing decisions on behalf of hospitals. The Company’s products consist of consoles that are marketed as stand-alone units or as units that can be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories, or cath labs. The Company has developed customized cath lab versions of these consoles. The Company sells products directly to customers in the United States, Japan, certain European markets and South Africa. The Company’s products include consoles, IVUS products, FFR products, Pioneer plus re-entry catheter and crux VCF system.